Tag Archives: NVCR

Top 5 Value Stocks To Own Right Now

In this segment of this Motley Fool Money podcast, host Chris Hill and Fool analysts Jason Moser, Matt Argersinger, and Ron Gross discuss the latest quarterly results from the world’s largest retailer.

Walmart (NYSE:WMT) beat on revenue and earnings, and its domestic online sales rose by 33% — which would be more impressive if it weren’t pouring quite so much money into its efforts to win those sales and if its margins weren’t feeling the pinch. They talk about Walmart’s strategy, its international plans, and whether the stock is a value or a value trap right now.

A full transcript follows the video.

This video was recorded on May 18, 2018.

Chris Hill: First quarter profits and revenue both came in higher than expected. Online sales in the U.S. up 33%. But, Ron, they are spending a lot of money.

Ron Gross: Yeah. It was mixed. You nailed it on the head. Beating expectations on the top and bottom line, that’s great. Comp sales up 2.1%, also strong. Online sales, last quarter, they actually disappointed on the online sales growth, and the stock took a slam. Now, up 33%. Really good to see, and that’s important. Online grocery also showing good, strong growth numbers as well. But, margins are under pressure. We’ve got higher freight costs, we’ve got price cuts to remain competitive, and that’s taking a bite out of profit. Operating income was actually down in the U.S. by about 3%. So, a mixed bag overall.

Top 5 Value Stocks To Own Right Now: Sohu.com Inc.(SOHU)

Advisors’ Opinion:

  • [By Anders Bylund]

    Sogou’s shares are prone to big swings for a couple of simple reasons.

    As a Chinese business, many American investors don’t feel connected to Sogou’s business and might not have access to some important sources of information about this company and its stock. Though Sogou has been around for nearly a decade now, it only entered the public markets in November of 2017. It’s a new ticker, untested on the market, and not always easily understood through year-over-year or longer-term analyses. At the IPO, Chinese internet giants Tencent (NASDAQOTH:TCEHY) and Sohu.com (NASDAQ:SOHU) combined for a total ownership of 82% of Sogu’s business. Those stakes later declined to 71%, but Sohu and Tencent remain Sogou’s largest shareholders, with 96% of the voting power in shareholder elections and votes. Regular investors hold a very small stake in Sogou, which tends to boost the stock’s volatility.

    Moreover, Chinese regulators launched an investigation of Sogou in June, forcing the company to shut down parts of its online advertising operations for 10 days in early July. The company is accused of showing video ads that insulted a national hero. That blackout will reduce Sogou’s third-quarter revenues by a significant but unannounced amount.

  • [By Rick Munarriz]

    I’ve been covering Sohu.com (NASDAQ:SOHU) for awhile, so when the Chinese internet pioneer announced plans to spin off Sogou, I was more than a little interested. Sogou has been the main growth driver at Sohu for years. With Sohu’s online advertising business meandering and its internet gaming business proving volatile, search has been its crown jewel.

  • [By Rick Munarriz]

    Sohu.com (NASDAQ:SOHU) is still struggling to fire on all cylinders, but investors nonetheless bid shares of the dot-com pioneer higher on Friday after it posted mixed fourth-quarter results. Revenue clocked in at $482.2 million for the final three months of 2018, a 5% decline from a year earlier, but a 5% sequential improvement. 

  • [By Daniel Sparks]

    Shares of Chinese internet company Sohu.com (NASDAQ:SOHU) fell as much as 11.8% on Wednesday, following the company’s first-quarter earnings release. The stock is down 8.4% at the time of this writing.

  • [By Rick Munarriz]

    The market isn’t warming up to Sohu.com’s (NASDAQ:SOHU) latest financial report. Its shares are hitting their lowest levels since the summer of 2007 after the Chinese online advertising, search, and gaming specialist posted disappointing first-quarter results on Wednesday morning. 

Top 5 Value Stocks To Own Right Now: Hudson Pacific Properties, Inc.(HPP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Forestar Group (NYSE: FOR) and Hudson Pacific Properties (NYSE:HPP) are both finance companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, risk and profitability.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Hudson Pacific Properties (HPP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Hudson Pacific Properties (NYSE:HPP) EVP Sanford Dale Shimoda sold 2,000 shares of the company’s stock in a transaction dated Friday, June 1st. The stock was sold at an average price of $35.72, for a total transaction of $71,440.00. Following the completion of the transaction, the executive vice president now owns 94,478 shares of the company’s stock, valued at approximately $3,374,754.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

  • [By Stephan Byrd]

    Hudson Pacific Properties (NYSE:HPP) EVP Sanford Dale Shimoda sold 5,000 shares of the firm’s stock in a transaction dated Wednesday, June 6th. The stock was sold at an average price of $35.96, for a total transaction of $179,800.00. Following the completion of the transaction, the executive vice president now owns 89,478 shares of the company’s stock, valued at $3,217,628.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

  • [By Stephan Byrd]

    Hudson Pacific Properties Inc (NYSE:HPP) has been given an average recommendation of “Buy” by the thirteen ratings firms that are presently covering the firm, Marketbeat reports. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $37.78.

Top 5 Value Stocks To Own Right Now: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    JPMorgan Chase & Co. reaffirmed their buy rating on shares of Novocure (NASDAQ:NVCR) in a report issued on Sunday morning.

    NVCR has been the subject of a number of other research reports. Mizuho reaffirmed a buy rating and issued a $32.00 price objective on shares of Novocure in a report on Wednesday, June 13th. BidaskClub downgraded shares of Novocure from a strong-buy rating to a buy rating in a report on Tuesday, July 31st. Evercore ISI began coverage on shares of Novocure in a report on Monday, July 16th. They issued an outperform rating and a $46.00 price objective for the company. Wedbush lifted their price objective on shares of Novocure from $33.00 to $40.00 and gave the stock an outperform rating in a report on Friday, July 27th. Finally, Deutsche Bank downgraded shares of Novocure from a buy rating to a hold rating in a report on Wednesday, July 25th. They noted that the move was a valuation call. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Novocure currently has an average rating of Buy and an average target price of $40.29.

  • [By Ethan Ryder]

    NovoCure (NASDAQ:NVCR) Director Gabriel Leung sold 80,000 shares of the firm’s stock in a transaction on Wednesday, May 16th. The stock was sold at an average price of $28.83, for a total value of $2,306,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Brian Feroldi]

    In this week’s episode of Industry Focus: Healthcare, hidden-gems aficionado Brian Feroldi shares three exciting healthcare small caps that don’t stick investors with a mountain of risk — LeMaitre Vascular (NASDAQ:LMAT), HealthEquity (NASDAQ:HQY), and NovoCure (NASDAQ:NVCR). What do these companies do? How did they carve out a niche for themselves? What does the competition look like? And, because you can’t mitigate all the risk away, what risks should investors watch for? Tune in and find out more.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on NovoCure (NVCR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Feroldi]

    After the company announced details of its phase 3 INNOVATE-3 trial at the American Society of Clinical Oncology (ASCO) annual meeting, shares of NovoCure (NASDAQ:NVCR), a red-hot medical device company focused on cancer, fell as much as 12% in early morning trading today. Shares were down about 10% as of 10:30 a.m. EDT.

  • [By Todd Campbell, Sean Williams, and Brian Feroldi]

    There have been more stock market pops and drops lately and that might have you wondering what healthcare stocks can be bought to take advantage of this volatility. Buying healthcare stocks during periods of volatility can be smart because demand for healthcare products and services usually isn’t discretionary. However, that doesn’t necessarily mean it makes sense to buy every healthcare stock out there. To find out what healthcare stocks it might make sense to buy this month, we asked top Motley Fool investors what companies are on their radar. In their view, Teva Pharmaceutical Industries (NYSE:TEVA), Novacure (NASDAQ:NVCR), and Galapagos (NASDAQ:GLPG) should be at the top of your idea list right now. Read on to find out why.

Top 5 Value Stocks To Own Right Now: Nuveen North Carolina Premium Income Municipal Fund(NNC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Wells Fargo & Company MN increased its holdings in Nuveen North Carol Premium Incom Mun Fd (NYSE:NNC) by 29.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 289,655 shares of the financial services provider’s stock after purchasing an additional 66,507 shares during the quarter. Wells Fargo & Company MN’s holdings in Nuveen North Carol Premium Incom Mun Fd were worth $3,554,000 at the end of the most recent reporting period.

Top 5 Value Stocks To Own Right Now: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TRADEMARK VIOLATION NOTICE: “Brian S. Dexheimer Sells 500 Shares of Plantronics (PLT) Stock” was originally posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3355123/brian-s-dexheimer-sells-500-shares-of-plantronics-plt-stock.html.

  • [By Logan Wallace]

    Plantronics (NYSE: PLT) and Ciena (NYSE:CIEN) are both mid-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends.

  • [By Stephan Byrd]

    Lapides Asset Management LLC reduced its position in shares of Plantronics Inc (NYSE:PLT) by 36.3% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 42,200 shares of the technology company’s stock after selling 24,100 shares during the quarter. Lapides Asset Management LLC’s holdings in Plantronics were worth $3,218,000 at the end of the most recent quarter.

  • [By Motley Fool Transcribers]

    Plantronics Inc  (NYSE:PLT)Q3 2019 Earnings Conference CallFeb. 05, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 10 Medical Stocks To Buy Right Now

Marijuana stocks are hot now, as is the social and political climate around them.

But true investors know that if you’re going to be a successful investor you have to be able to spot objective opportunities and not be pulled by emotional or political feelings.

Few issues exemplify this more than the new wave of cannabis legislation sweeping the country.

At this point, recreational marijuana is legal in nine states and medical marijuana is legal in 30. That’s 60% of the U.S. states that see some reason to legalize marijuana. And cannabidiol (CBD) a non-psychoactive ingredient found in marijuana is legal in 17 states to treat children with epilepsy or severe seizures.

Canada has also legalized recreational marijuana and it has some of the most mature cannabis companies in North America.

Because the U.S. is still a patchwork of states that allow limited, full or no use of legal cannabis, it’s a challenge for an industry — and by extension marijuana stocks — to truly develop. What you have is companies that have moved into the most open cannabis markets to establish themselves in the hopes of being able to scale up their business nationally, when the time comes.

Top 10 Medical Stocks To Buy Right Now: Sealed Air Corporation(SEE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Sealed Air (SEE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Sealed Air (SEE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Shares of Seeing Machines Limited (LON:SEE) rose 17.3% during mid-day trading on Tuesday . The stock traded as high as GBX 9.70 ($0.13) and last traded at GBX 9.15 ($0.12). Approximately 28,492,209 shares traded hands during mid-day trading, an increase of 461% from the average daily volume of 5,080,000 shares. The stock had previously closed at GBX 7.80 ($0.10).

Top 10 Medical Stocks To Buy Right Now: CNB Financial Corporation(CCNE)

Advisors’ Opinion:

  • [By Stephan Byrd]

    ILLEGAL ACTIVITY WARNING: “CNB Financial (CCNE) Rating Lowered to Sell at Zacks Investment Research” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.tickerreport.com/banking-finance/3370450/cnb-financial-ccne-rating-lowered-to-sell-at-zacks-investment-research.html.

  • [By Ethan Ryder]

    CNB Financial (NASDAQ:CCNE) was downgraded by research analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a research report issued to clients and investors on Friday.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on CNB Financial (CCNE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    BidaskClub upgraded shares of CNB Financial (NASDAQ:CCNE) from a hold rating to a buy rating in a research note released on Wednesday morning.

    Several other equities research analysts have also issued reports on CCNE. Boenning Scattergood reissued a buy rating and set a $29.50 price target on shares of CNB Financial in a research report on Monday, February 5th. Zacks Investment Research lowered CNB Financial from a buy rating to a sell rating in a research report on Tuesday, February 20th. ValuEngine raised CNB Financial from a buy rating to a strong-buy rating in a research report on Monday, April 2nd. Finally, Keefe, Bruyette & Woods initiated coverage on CNB Financial in a research report on Tuesday, April 10th. They set a market perform rating and a $35.00 price target on the stock. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $31.50.

Top 10 Medical Stocks To Buy Right Now: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Novocure (NASDAQ:NVCR) and Anika Therapeutics (NASDAQ:ANIK) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.

  • [By Brian Feroldi]

    In this week’s episode of Industry Focus: Healthcare, hidden-gems aficionado Brian Feroldi shares three exciting healthcare small caps that don’t stick investors with a mountain of risk — LeMaitre Vascular (NASDAQ:LMAT), HealthEquity (NASDAQ:HQY), and NovoCure (NASDAQ:NVCR). What do these companies do? How did they carve out a niche for themselves? What does the competition look like? And, because you can’t mitigate all the risk away, what risks should investors watch for? Tune in and find out more.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Novocure (NVCR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Chris Lange]

    Novocure Ltd. (NASDAQ: NVCR) announced results from its Phase 3 INNOVATE trial of TTFields in platinum-resistant ovarian cancer. There were no major surprises, except study size is larger than some investors expected, which is not concerning. INNOVATE-3 is set to start later this year and as previously announced will enroll patients with recurrent platinum-resistant ovarian cancer.

  • [By Chris Lange]

    NocoCure Ltd. (NASDAQ: NVCR) is scheduled to release its fourth-quarter earnings report on February 22 as well. The consensus estimates call for a net loss of $0.11 per share and $53.52 million in revenue. The same period of last year had a net loss of $0.26 per share and $30.24 million in revenue. Shares of Novocure most recently closed at $21.50, with a consensus price target of $27.00 and a 52-week range of $6.75 to $24.15.

Top 10 Medical Stocks To Buy Right Now: MINDBODY, Inc.(MB)

Advisors’ Opinion:

  • [By Shane Hupp]

    MINDBODY (NASDAQ:MB) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c” rating in a research note issued on Monday.

  • [By Joseph Griffin]

    MINDBODY Inc (NASDAQ:MB) insider Kimberly Gail Lytikainen sold 641 shares of MINDBODY stock in a transaction that occurred on Tuesday, August 28th. The shares were sold at an average price of $36.89, for a total transaction of $23,646.49. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

  • [By Beth McKenna]

    Mindbody (NASDAQ:MB) reported second-quarter 2018 financial results after the market close on Tuesday. The online platform provider for the fitness, wellness, and beauty services industries posted strong revenue growth of 40% year over year. Net loss per share on both a GAAP and adjusted basis widened, driven by acquisitions and increased spending intended to fuel long-term growth. 

  • [By Joseph Griffin]

    Shares of Mindbody Inc. (NASDAQ:MB) have received a consensus recommendation of “Buy” from the fourteen research firms that are presently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, three have assigned a hold rating, eight have issued a buy rating and two have issued a strong buy rating on the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $36.72.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Extreme Networks, Inc. (NASDAQ: EXTR) fell 26 percent to $8.70 in pre-market trading after the company reported downbeat earnings for its third quarter and issued weak Q4 guidance.
    Caesarstone Ltd. (NASDAQ: CSTE) shares fell 12.5 percent to $16.15 in pre-market trading after the company reported downbeat Q1 results and lowered its FY18 sales forecast.
    MINDBODY, Inc. (NASDAQ: MB) fell 11.7 percent to $38.65 in pre-market trading following mixed Q1 results.
    Vivint Solar, Inc. (NYSE: VSLR) fell 10 percent to $3.60 in pre-market trading after reporting Q1 miss.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) shares fell 10 percent to $31.63 in pre-market trading after reporting a Q1 earnings miss at 28 cents per share, 5 cents below estimates.
    Monster Beverage Corporation (NASDAQ: MNST) fell 7.7 percent to $49.00 in pre-market trading after reporting downbeat quarterly earnings.
    MaxLinear, Inc. (NYSE: MXL) fell 6.1 percent to $22.39 in pre-market trading following Q1 earnings.
    Virtu Financial, Inc. (NASDAQ: VIRT) fell 5.3 percent to $31.1604 in pre-market trading after announcing a 15 million share common stock secondary offering.
    Papa John's International, Inc. (NASDAQ: PZZA) shares fell 4.7 percent to $56 in pre-market trading after reporting downbeat Q1 earnings

  • [By Shane Hupp]

    MINDBODY (NASDAQ: MB) and Sphere 3D (NASDAQ:ANY) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.

Top 10 Medical Stocks To Buy Right Now: WEX Inc.(WEX)

Advisors’ Opinion:

  • [By Shane Hupp]

    United Services Automobile Association cut its holdings in WEX Inc (NYSE:WEX) by 2.9% in the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 165,327 shares of the business services provider’s stock after selling 4,970 shares during the quarter. United Services Automobile Association owned about 0.38% of WEX worth $31,491,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Formula Growth Ltd. decreased its position in WEX Inc (NYSE:WEX) by 6.5% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,200 shares of the business services provider’s stock after selling 1,200 shares during the period. Formula Growth Ltd.’s holdings in WEX were worth $3,276,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on WEX (WEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on WEX (WEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on WEX (WEX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Buy Right Now: Glu Mobile Inc.(GLUU)

Advisors’ Opinion:

  • [By Rick Munarriz]

    Tuesday was rough for Glu Mobile (NASDAQ:GLUU) investors. Shares of the mobile gaming company plunged 13% after it posted poorly received fourth-quarter results. It’s a big hit for one of the hottest mobile gaming stocks over the past couple of years, but it’s not much a setback when you stretch out your horizon beyond Tuesday’s trading day. 

  • [By Harsh Chauhan]

    Glu Mobile (NASDAQ:GLUU) stock has more than doubled over the past year, getting a recent boost from an impressive first-quarter report that revealed all-round improvements in the company’s business. This is a massive turnaround for Glu as Wall Street wasn’t convinced about Glu’s ability to grow profitably at this point last year, when its losses were mounting, but it now seems to have put those speculations to rest quite emphatically.

  • [By Jamal Carnette, CFA]

    Although it’s far beneath Wall Street’s radar, Glu Mobile (NASDAQ:GLUU) stock has quietly had an amazing year. On a year-over-year basis, shares of the mobile app game developer have advanced 120% versus 19% for the Russell 2000 small-cap index. Still, it would be a folly to call Glu Mobile’s public-market performance a success. Shares are down 45% since its 2007 IPO, while the index has increased 140%.

  • [By Rick Munarriz]

    Zoe’s Kitchen (NYSE:ZOES), Sogou (NYSE:SOGO), and Glu Mobile (NASDAQ:GLUU) are three names currently trading on the wrong side of $10, but their prospects are brighter than their sticker prices. Let’s go over why they may be among the top stocks under $10. 

  • [By Lee Jackson]

    This gaming stock could have some big upside for aggressive accounts. Glu Mobile Inc. (NASDAQ: GLUU) develops, publishes and markets a portfolio of mobile games. The company develops and publishes a portfolio of mobile games designed to appeal to a cross-section of the users of smartphones and tablet devices.

  • [By Steve Symington]

    Shares of Glu Mobile Inc. (NASDAQ:GLUU) fell more than 12% on Monday after ROTH Capital analyst Darren Aftahi downgraded the free-to-play mobile game specialist to neutral from buy. He also reduced his per-share price target on Glu Mobile by a quarter to $8, marking a more modest premium from Friday’s closing price of $7.20.

Top 10 Medical Stocks To Buy Right Now: America’s Car-Mart Inc.(CRMT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    America’s Car-Mart, Inc. (NASDAQ:CRMT) – Research analysts at Jefferies Group cut their Q1 2019 earnings per share (EPS) estimates for America’s Car-Mart in a research note issued on Tuesday, May 22nd. Jefferies Group analyst J. Hecht now expects that the company will post earnings of $1.08 per share for the quarter, down from their previous forecast of $1.21. Jefferies Group also issued estimates for America’s Car-Mart’s Q3 2019 earnings at $0.75 EPS, FY2019 earnings at $4.40 EPS, Q2 2020 earnings at $0.96 EPS, Q3 2020 earnings at $0.95 EPS and FY2020 earnings at $5.10 EPS.

  • [By Joseph Griffin]

    Equities research analysts expect that America’s Car-Mart, Inc. (NASDAQ:CRMT) will announce sales of $166.46 million for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for America’s Car-Mart’s earnings, with the lowest sales estimate coming in at $164.60 million and the highest estimate coming in at $168.31 million. America’s Car-Mart reported sales of $149.12 million during the same quarter last year, which would suggest a positive year over year growth rate of 11.6%. The business is expected to report its next quarterly earnings report on Thursday, November 15th.

  • [By Jon C. Ogg]

    According to the Merrill Lynch views on the rise in older car models, this is expected to benefit dealers such as CarMax Inc. (NYSE: KMX) and America’s Car-Mart Inc. (NASDAQ: CRMT), as well as auctioneer KAR Auction Services Inc. (NYSE: KAR).

Top 10 Medical Stocks To Buy Right Now: HD Supply Holdings, Inc.(HDS)

Advisors’ Opinion:

  • [By Max Byerly]

    Andra AP fonden purchased a new position in shares of HD Supply Holdings Inc (NASDAQ:HDS) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 308,500 shares of the industrial products company’s stock, valued at approximately $13,232,000. HD Supply makes up 0.4% of Andra AP fonden’s investment portfolio, making the stock its 2nd largest position.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on HD Supply (HDS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Staff]

    HD Supply Holdings, Inc. (NASDAQ:HDS)Q1 2018 Earnings Conference CallJune 5, 2018, 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Garrett Baldwin]

    Starbuck’s Corp. (Nasdaq: SBUX) Executive Chair Howard Schultz announced he will depart the company. Many are speculating he will pursue a career in politics and potentially seek the Democratic nomination for president in 2020. Schultz had previously denied any speculation around a role in government; but his recent comments suggest that “public service” will be a part of his future plans. Gold prices dipped below $1,300 per ounce as markets continue to speculate on the likelihood of additional interest rate hikes in 2018. We believe this is solid buying opportunity for investors. The reason why gold is going to get a nice boost: ongoing trade tensions between the United States and the rest of the globe. Money Morning Resource Specialist Peter Krauth provides his insight on where gold prices are heading next and how you can make big gains in the weeks ahead.
    Three Stocks to Watch Today: AAPL, TWTR, SCGLF
    Apple Inc. (Nasdaq: AAPL) is on the verge of becoming the world’s first $1 trillion company. The stock pushed above $192.60 per share in pre-market hours after its first day at the Worldwide Developers Conference. During the event, the company unveiled its new mobile operating system, called iOS 12. The firm also unveiled a suite of tools designed to combat technology addiction. Shares of Twitter Inc. (NYSE: TWTR) jumped nearly 4% on news that the social media company is about to join the S&P 500. The company will join on Thursday morning and will replace agribusiness giant Monsanto Co. (NYSE: MON). The news comes as Monsanto is in the final steps of its merger with German chemical giant Bayer AG (Nasdaq: BAYRY). Shares of Societe Generale SA (ADR) (OTCMKTS: SCGLF) are in focus after the U.S. Justice Department announced the French investment bank will pay $1.3 billion to settle two ongoing legal headaches. The company bribed Libyan officials and manipulated LIBOR, a benchmark interest rate on which most financing is based. Legg Mason Inc. (NYSE: L

  • [By Shane Hupp]

    HD Supply Holdings Inc (NASDAQ:HDS) reached a new 52-week high during trading on Tuesday . The company traded as high as $45.77 and last traded at $45.69, with a volume of 53848 shares. The stock had previously closed at $45.03.

Top 10 Medical Stocks To Buy Right Now: Citrix Systems Inc.(CTXS)

Advisors’ Opinion:

  • [By Max Byerly]

    Qube Research & Technologies Ltd lifted its position in shares of Citrix Systems, Inc. (NASDAQ:CTXS) by 153.7% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,212 shares of the cloud computing company’s stock after purchasing an additional 1,340 shares during the period. Qube Research & Technologies Ltd’s holdings in Citrix Systems were worth $232,000 as of its most recent SEC filing.

  • [By Ethan Ryder]

    LogMeIn (NASDAQ: LOGM) and Citrix Systems (NASDAQ:CTXS) are both computer and technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, risk, profitability and institutional ownership.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Citrix Systems (CTXS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Citrix Systems (CTXS)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By VantagePoint]

    Citrix Systems, Inc. (NASDAQ: CTXS) had a very clear crossover to the upside on April 11, and since that day's close the stock is up 15 percent. This one is interesting also because the two moving averages have also recently diverged even further, indicating that the uptrend has only gotten stronger since the company posted an excellent Q1 earnings and Q2 guidance report that came in well above Wall Street's expectations. 

  • [By Max Byerly]

    Here are some of the news stories that may have effected Accern Sentiment Analysis’s rankings:

    Get Citrix Systems alerts:

    Citrix Systems (CTXS) VP Jessica Soisson Sells 3,281 Shares (americanbankingnews.com) Glancy Prongay & Murray LLP Continues Investigation on Behalf of Citrix Systems, Inc. (CTXS) Investors (bizjournals.com) Glancy Prongay & Murray LLP Continues Investigation on Behalf of Citrix Systems, Inc. (CTXS) Investors (markets.financialcontent.com) Citrix Michael Lewis Day 3 Highlights from Synergy 2018 (dabcc.com) Citrix Certification Guide: Overview and Career Paths (businessnewsdaily.com)

    A number of brokerages have commented on CTXS. Mizuho reaffirmed a “buy” rating on shares of Citrix Systems in a report on Wednesday, May 9th. Zacks Investment Research raised Citrix Systems from a “hold” rating to a “strong-buy” rating and set a $118.00 price objective on the stock in a report on Tuesday, May 1st. Goldman Sachs raised Citrix Systems from a “buy” rating to a “conviction-buy” rating in a report on Tuesday, May 1st. Royal Bank of Canada upped their price objective on Citrix Systems to $104.00 and gave the company a “market perform” rating in a report on Thursday, April 26th. Finally, Barclays upped their price objective on Citrix Systems from $90.00 to $100.00 and gave the company an “equal weight” rating in a report on Thursday, April 26th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating, six have given a buy rating and three have given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $102.31.

Top 10 Medical Stocks To Buy Right Now: Wayfair Inc.(W)

Advisors’ Opinion:

  • [By Max Byerly]

    Wayfair (NYSE:W) had its price objective increased by stock analysts at Buckingham Research from $95.00 to $137.00 in a research note issued to investors on Wednesday. The brokerage currently has a “buy” rating on the stock. Buckingham Research’s price objective would suggest a potential upside of 19.88% from the company’s previous close.

  • [By Max Byerly]

    Wayfair Inc (NYSE:W) shares hit a new 52-week high during trading on Thursday after Loop Capital raised their price target on the stock to $140.00. Loop Capital currently has a buy rating on the stock. Wayfair traded as high as $117.90 and last traded at $118.48, with a volume of 86952 shares trading hands. The stock had previously closed at $111.19.

  • [By Max Byerly]

    Miller Value Partners LLC cut its stake in Wayfair Inc (NYSE:W) by 33.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 430,095 shares of the company’s stock after selling 220,605 shares during the quarter. Wayfair comprises approximately 1.9% of Miller Value Partners LLC’s holdings, making the stock its 28th largest holding. Miller Value Partners LLC owned approximately 0.48% of Wayfair worth $51,078,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Wayfair Inc (NYSE:W) insider Steve Oblak sold 3,570 shares of the firm’s stock in a transaction dated Thursday, June 21st. The shares were sold at an average price of $114.31, for a total value of $408,086.70. Following the completion of the transaction, the insider now directly owns 119,382 shares in the company, valued at $13,646,556.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Top 10 Low Price Stocks To Buy For 2019

Wal-Mart (NYSE:WMT) has made a lot of efforts in pricing its goods attractively over the past months. This allowed for strong traffic growth, which resulted in positive comps for the company. Subsequently, Wal-Mart’s shares have been performing much better than those of its peers, which are reporting worse comp sales. Due to Wal-Mart’s power when it comes to discussing prices with its suppliers, the company is able to price its goods attractively whilst generating strong margins, which, in turn, means that the earnings power of Wal-Mart remains high (despite the low prices Wal-Mart offers its goods at), which makes Wal-Mart a compelling retail investment.

Top 10 Low Price Stocks To Buy For 2019: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on NovoCure (NVCR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Brian Feroldi]

    After the company reported first-quarter results, shares of NovoCure (NASDAQ:NVCR), a medical device company focused on cancer, jumped as much as 10% in afternoon trading on Thursday. Shares closed the day up more than 9%.

  • [By Chris Lange]

    Novocure Ltd. (NASDAQ: NVCR) announced results from its Phase 3 INNOVATE trial of TTFields in platinum-resistant ovarian cancer. There were no major surprises, except study size is larger than some investors expected, which is not concerning. INNOVATE-3 is set to start later this year and as previously announced will enroll patients with recurrent platinum-resistant ovarian cancer.

  • [By Todd Campbell, Sean Williams, and Brian Feroldi]

    There have been more stock market pops and drops lately and that might have you wondering what healthcare stocks can be bought to take advantage of this volatility. Buying healthcare stocks during periods of volatility can be smart because demand for healthcare products and services usually isn’t discretionary. However, that doesn’t necessarily mean it makes sense to buy every healthcare stock out there. To find out what healthcare stocks it might make sense to buy this month, we asked top Motley Fool investors what companies are on their radar. In their view,Teva Pharmaceutical Industries (NYSE:TEVA), Novacure (NASDAQ:NVCR), and Galapagos (NASDAQ:GLPG)should be at the top of your idea list right now. Read on to find out why.

  • [By Lee Jackson]

    This stock has been on a roll and looks ready to break out. NovoCure Ltd. (NASDAQ: NVCR) develops and commercializes treatments for solid tumor cancer therapy called the tumor treating fields (TTFields). Its markets its proprietary TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer.

  • [By Ethan Ryder]

    NovoCure (NASDAQ:NVCR) Director Gabriel Leung sold 80,000 shares of the firm’s stock in a transaction on Wednesday, May 16th. The stock was sold at an average price of $28.83, for a total value of $2,306,400.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Top 10 Low Price Stocks To Buy For 2019: MFS Charter Income Trust(MCR)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Macro (CURRENCY:MCR) traded flat against the U.S. dollar during the 24 hour period ending at 20:00 PM E.T. on May 30th. During the last seven days, Macro has traded down 6% against the U.S. dollar. Macro has a total market cap of $0.00 and approximately $0.00 worth of Macro was traded on exchanges in the last day. One Macro token can now be bought for about $0.17 or 0.00002339 BTC on popular cryptocurrency exchanges.

Top 10 Low Price Stocks To Buy For 2019: Xerium Technologies Inc.(XRM)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media coverage about Xerium Technologies (NYSE:XRM) has trended somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Xerium Technologies earned a news impact score of 0.17 on Accern’s scale. Accern also assigned press coverage about the industrial products company an impact score of 47.7306467260184 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Top 10 Low Price Stocks To Buy For 2019: Carter's, Inc.(CRI)

Advisors’ Opinion:

  • [By Steve Symington]

    Carter’s Inc.(NYSE:CRI)announced first-quarter 2018 results on Thursday morning, detailing a strong performance in spite of the negative impact of the recent bankruptcy of Toy “R” Us on its large wholesale segment. Though shares initially fell almost 5% early on, Carter’s stock recovered to trade modestly higher by this afternoon.

  • [By Joseph Griffin]

    UBS Group initiated coverage on shares of Carter’s (NYSE:CRI) in a research note published on Thursday morning, www.benzinga.com reports. The firm issued a neutral rating and a $114.00 price target on the textile maker’s stock.

  • [By Joseph Griffin]

    Carter’s, Inc. (NYSE:CRI) was the recipient of some unusual options trading activity on Tuesday. Stock investors purchased 2,108 put options on the company. This represents an increase of approximately 1,560% compared to the average daily volume of 127 put options.

  • [By Ethan Ryder]

    Carter’s, Inc. (NYSE:CRI) has earned a consensus recommendation of “Buy” from the fifteen ratings firms that are covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and ten have given a buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $120.27.

  • [By Max Byerly]

    Dimensional Fund Advisors LP grew its holdings in shares of Carter’s, Inc. (NYSE:CRI) by 2.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 450,812 shares of the textile maker’s stock after purchasing an additional 9,306 shares during the period. Dimensional Fund Advisors LP owned approximately 0.96% of Carter’s worth $46,930,000 at the end of the most recent reporting period.

Top 10 Low Price Stocks To Buy For 2019: Merrimack Pharmaceuticals, Inc.(MACK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the media headlines that may have effected Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Edited Transcript of MACK earnings conference call or presentation 8-May-18 12:30pm GMT (finance.yahoo.com) Investors Purchase High Volume of Merrimack Pharmaceuticals Call Options (MACK) (americanbankingnews.com) Merrimack (MACK) Reports Wider-Than-Expected Loss in Q1 (finance.yahoo.com) Merrimack Pharmaceuticals (MACK) Announces Quarterly Earnings Results, Misses Expectations By $0.05 EPS (americanbankingnews.com) Merrimack Pharmaceuticals’ (MACK) CEO Richard Peters on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com)

    A number of equities analysts have issued reports on MACK shares. Robert W. Baird reiterated a “hold” rating and issued a $12.00 price objective on shares of Merrimack Pharmaceuticals in a report on Thursday, March 15th. Zacks Investment Research upgraded Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective for the company in a report on Wednesday, April 25th.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell.
    Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million.
    Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter.
    Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss.
    Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering.
    Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday.
    Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading.
    Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday.
    vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday.
    Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results.
    Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday.
    Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report.
    GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading.
    Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market

  • [By Max Byerly]

    Here are some of the media stories that may have impacted Accern Sentiment Analysis’s rankings:

    Get Merrimack Pharmaceuticals alerts:

    Biotech Stock Roundup: PBYI Soars, MACK Crashes, GILD's Biktarvy Gets EC Nod (finance.yahoo.com) Merrimack Fails Phase 2 Pancreatic Cancer Study, But Opportunity Remains (seekingalpha.com) Merrimack Pharmaceuticals’ (MACK) “Hold” Rating Reaffirmed at Robert W. Baird (americanbankingnews.com) Merrimack Crashes as Phase II Pancreatic Cancer Study Fails (zacks.com) MM-141 (benzinga.com)

    Several equities analysts have commented on MACK shares. Zacks Investment Research raised Merrimack Pharmaceuticals from a “hold” rating to a “buy” rating and set a $9.50 price objective on the stock in a research report on Wednesday, April 25th. JPMorgan Chase & Co. downgraded Merrimack Pharmaceuticals from a “neutral” rating to an “underweight” rating in a research report on Monday. Robert W. Baird cut their price objective on Merrimack Pharmaceuticals from $12.00 to $7.00 and set a “neutral” rating on the stock in a research report on Tuesday. Finally, ValuEngine raised Merrimack Pharmaceuticals from a “sell” rating to a “hold” rating in a research report on Tuesday.

  • [By Chris Lange]

    Merrimack Pharmaceuticals Inc. (NASDAQ: MACK) shares were absolutely crushed on Monday after the firm gave an update from its midstage pancreatic cancer study. Specifically, the top-line results come from the CARRIE study, a randomized Phase 2 trial evaluating the addition of MM-141 (istiratumab) to standard-of-care treatment in patients with previously untreated metastatic pancreatic cancer.

Top 10 Low Price Stocks To Buy For 2019: MPLX LP(MPLX)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    MPLX (NYSE:MPLX) has undergone a significant transformation over the past year and a half. The master limited partnership (MLP) completed several transactions with its oil refining parent Marathon Petroleum (NYSE:MPC), which diversified its midstream portfolio and eliminated costly management fees. Those moves position MPLX to continue growing its rock-solid 6.8%-yielding payout at a healthy clip for the next several years, making it an excellent option for income-seeking investors to consider buying.

  • [By Matthew DiLallo]

    The market gave income-seeking investors a gift in June by selling off units of MPLX (NYSE:MPLX), a midstream master limited partnership (MLP).For the month, the pipeline company inexplicably lost about 5% of its value, pushing it down about 4% for the year. Because of that, it trades at an attractive valuation and now yields 7.3%. Those are just some of the factors that make it a compelling income stock to consider buying this month.

  • [By Tyler Crowe]

    So in this spirit, I thought I would share with you a stock you may want to consider for your own portfolio because it is one I have recently purchased myself: oil and gas logistics player MPLX LP (NYSE:MPLX). Here’s why I think it is a company worthy of investment and the recent change to the business that compelled me to buy this stock.

Top 10 Low Price Stocks To Buy For 2019: Xplore Technologies Corp(XPLR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Xplore Technologies (NASDAQ: XPLR) is one of 25 publicly-traded companies in the “Computer & office equipment” industry, but how does it compare to its peers? We will compare Xplore Technologies to related businesses based on the strength of its dividends, profitability, earnings, risk, valuation, analyst recommendations and institutional ownership.

  • [By Ethan Ryder]

    Xplore Technologies (NASDAQ: XPLR) and Echelon (NASDAQ:ELON) are both small-cap computer and technology companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

  • [By Chris Lange]

    Xplore Technologies Corp. (NASDAQ: XPLR) shares spiked on Thursday after it was announced that the company would be acquired by Zebra Technologies Corp. (NASDAQ: ZBRA). The transaction is subject to customary closing conditions and is expected to close in the third quarter of 2018.

  • [By Logan Wallace]

    A10 Networks (NYSE: ATEN) and Xplore Technologies (NASDAQ:XPLR) are both small-cap computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, dividends and valuation.

Top 10 Low Price Stocks To Buy For 2019: American Capital Mortgage Investment Corp.(MTGE)

Advisors’ Opinion:

  • [By Max Byerly]

    BidaskClub upgraded shares of MTGE Investment (NASDAQ:MTGE) from a hold rating to a buy rating in a research note published on Thursday.

    A number of other brokerages have also weighed in on MTGE. Keefe, Bruyette & Woods lowered shares of MTGE Investment from an outperform rating to a market perform rating in a research report on Monday, May 7th. Maxim Group lowered shares of MTGE Investment from a buy rating to a hold rating and cut their target price for the company from $21.00 to $19.75 in a research report on Friday, May 4th. Finally, ValuEngine lowered shares of MTGE Investment from a buy rating to a hold rating in a research report on Wednesday, May 2nd.

Top 10 Low Price Stocks To Buy For 2019: Synopsys, Inc.(SNPS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Synopsys (NASDAQ:SNPS) had its price target raised by stock analysts at KeyCorp from $110.00 to $112.00 in a research report issued to clients and investors on Thursday. The firm currently has an “overweight” rating on the semiconductor company’s stock. KeyCorp’s price target would suggest a potential upside of 26.81% from the stock’s current price.

  • [By Logan Wallace]

    These are some of the news headlines that may have effected Accern Sentiment’s analysis:

    Get Synopsys alerts:

    Synopsys, Inc. (SNPS) Receives Average Rating of “Buy” from Brokerages (americanbankingnews.com) Free Research Report as Applied Materials Revenues Grew 28.8%; Adjusted EPS Surged 54.4% (finance.yahoo.com) Synopsys IC Validator Certified by Samsung Foundry for 7nm Signoff Physical Verification (prnewswire.com) Synopsys Fusion Technology Enables Lower Power, Smaller Area, and Higher Performance on Samsung Foundry 7LPP Process with EUV (prnewswire.com) Synopsys Announces New Release of LucidShape Software for Automotive Lighting Design and Analysis (finance.yahoo.com)

    A number of equities analysts recently commented on SNPS shares. KeyCorp reaffirmed an “overweight” rating and set a $110.00 price target (up from $106.00) on shares of Synopsys in a research note on Thursday, February 22nd. Royal Bank of Canada reaffirmed a “buy” rating on shares of Synopsys in a research note on Friday, February 23rd. Zacks Investment Research cut shares of Synopsys from a “hold” rating to a “strong sell” rating in a research note on Monday, February 26th. BidaskClub cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Tuesday, February 27th. Finally, ValuEngine raised shares of Synopsys from a “hold” rating to a “buy” rating in a research report on Thursday, April 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. Synopsys presently has an average rating of “Buy” and an average target price of $102.71.

  • [By Joseph Griffin]

    Champlain Investment Partners LLC boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 3.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 686,287 shares of the semiconductor company’s stock after purchasing an additional 25,685 shares during the period. Champlain Investment Partners LLC owned about 0.46% of Synopsys worth $57,127,000 as of its most recent filing with the SEC.

Top 10 Low Price Stocks To Buy For 2019: B. Riley Financial, Inc.(RILY)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Standard General L.P.’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Standard+General+L.P.

    These are the top 5 holdings of Standard General L.P.National CineMedia Inc (NCMI) – 12,576,000 shares, 60.53% of the total portfolio. New PositionTime Inc (TIME) – 3,181,424 shares, 29.62% of the total portfolio. Turning Point Brands Inc (TPB) – 305,319 shares, 3.58% of the total portfolio. Shares added by 189.90%CafePress Inc (PRSS) – 2,500,000 shares, 3.12% of the total portfolio. New PositionB. Riley Financial Inc (RILY) – 167,736 shares, 1.97% of the total portfoli

  • [By Stephan Byrd]

    Broadridge Financial Solutions (NYSE: BR) and B. Riley Financial (NASDAQ:RILY) are both business services companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, profitability, earnings, analyst recommendations, institutional ownership and dividends.

Top 10 Gold Stocks To Watch Right Now

Disney Land. The Grand Canyon. The Golden Gate Bridge. Yosemite. The World Trade Center.

The United States has long been a bucket-list destination, but as executive announcement piles on executive announcement, international visitors are wary of choosing the tourism-behemoth for their next vacation.

Forbes

Inbound arrivals have fallen 1.4% since January, while global arrivals have jumped 4.6%, leading many travel industry experts to say the ‘Trump Slump’ is real. Credit: Nick DeSantis, Forbes.

After the announcement of the first two travel bans in January and March, the number of international travelers arriving in the U.S. has dramatically dropped, according to ForwardKeys, a European travel-prediction firm.

Top 10 Gold Stocks To Watch Right Now: Salesforce.com Inc(CRM)

Advisors’ Opinion:

  • [By ]

    The seven companies cited by Cramer are Salesforce.com Inc.  (CRM) , Workday Inc. (WDAY) , ServiceNow Inc. (NOW) , Splunk Inc. (SPLK) , New Relic Inc. (NEWR) , VMWare Inc. (VMW) , and Adobe Systems Incorporated (ADBE) .

  • [By Joseph Griffin]

    Salesforce.com (NYSE:CRM) had its price target increased by JMP Securities from $126.00 to $140.00 in a research note published on Tuesday. The brokerage currently has a market outperform rating on the CRM provider’s stock.

  • [By Nicholas Rossolillo]

    Salesforce.com (NYSE:CRM) CEO Marc Benioff often talks about having a beginner’s mind — trying to view the world like it’s a new place you’ve never experienced before. That thinking is leading the company toward developing a blockchain and cryptocurrency solution that Benioff hopes will be ready for the company’s Dreamforce 2018 software conference this September. For investors, that means Salesforce could be the latest way to take advantage of the cryptocurrency boom … without having to buy any bitcoin.

Top 10 Gold Stocks To Watch Right Now: Camping World Holdings, Inc. (CWH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Metropolitan Life Insurance Co. NY trimmed its position in Camping World (NYSE:CWH) by 37.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 10,006 shares of the company’s stock after selling 6,077 shares during the quarter. Metropolitan Life Insurance Co. NY’s holdings in Camping World were worth $448,000 at the end of the most recent reporting period.

  • [By Paul Ausick]

    Camping World Holdings Inc. (NYSE: CWH) traded down about 13% Wednesday to post a new 52-week low of $18.65 after closing Tuesday at $21.41. The stock’s 52-week high is $47.62. Volume was almost four times the daily average of around 1.7 million shares. The company had no specific news.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o

Top 10 Gold Stocks To Watch Right Now: POSCO(PKX)

Advisors’ Opinion:

  • [By Max Byerly]

    Media coverage about POSCO (NYSE:PKX) has trended somewhat positive on Saturday, according to Accern Sentiment Analysis. The research firm scores the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. POSCO earned a news sentiment score of 0.22 on Accern’s scale. Accern also gave news headlines about the basic materials company an impact score of 46.5366586800129 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Top 10 Gold Stocks To Watch Right Now: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Brian Feroldi]

    After the company reported first-quarter results, shares of NovoCure (NASDAQ:NVCR), a medical device company focused on cancer, jumped as much as 10% in afternoon trading on Thursday. Shares closed the day up more than 9%.

  • [By Lee Jackson]

    This stock has been on a roll and looks ready to break out. NovoCure Ltd. (NASDAQ: NVCR) develops and commercializes treatments for solid tumor cancer therapy called the tumor treating fields (TTFields). Its markets its proprietary TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on NovoCure (NVCR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Gold Stocks To Watch Right Now: Rexnord Corporation(RXN)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Rexnord (NYSE:RXN) announced its quarterly earnings results on Monday. The industrial products company reported $0.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.01), reports. Rexnord had a net margin of 8.29% and a return on equity of 13.05%.

  • [By Motley Fool Staff]

    Rexnord Corporation (NYSE:RXN) Q4 2018 Earnings Conference CallMay. 15, 2018 8:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Agilent Technologies, Inc. (NYSE: A) is estimated to post quarterly earnings at $0.64 per share on revenue of $1.21 billion.
    Vipshop Holdings Limited (NYSE: VIPS) is expected to post quarterly earnings at $0.18 per share on revenue of $3.10 billion.
    Rexnord Corporation (NYSE: RXN) is projected to post quarterly earnings at $0.39 per share on revenue of $551.94 million.
    Invitation Homes Inc. (NYSE: INVH) is estimated to post quarterly earnings at $0.03 per share on revenue of $423.13 million.
    Switch, Inc. (NYSE: SWCH) is expected to post quarterly earnings at $0.05 per share on revenue of $99.83 million.
    Itron, Inc. (NASDAQ: ITRI) is projected to post quarterly earnings at $0.13 per share on revenue of $579.85 million.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) is expected to post quarterly earnings at $0.44 per share on revenue of $119.06 million.
    Amyris, Inc. (NASDAQ: AMRS) is estimated to post quarterly earnings at $0.07 per share on revenue of $68.14 million.
    Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) is projected to post quarterly loss at $0.38 per share on revenue of $1.87 million.
    VOXX International Corporation (NASDAQ: VOXX) is expected to post quarterly earnings at $0.05 per share on revenue of $130.00 million.
    Phoenix New Media Limited (NYSE: FENG) is estimated to post quarterly loss at $0.12 per share on revenue of $45.38 million.
    Restoration Robotics, Inc. (NASDAQ: HAIR) is projected to post quarterly loss at $0.17 per share on revenue of $5.93 million.
    YogaWorks, Inc. (NASDAQ: YOGA) is estimated to post quarterly loss at $0.22 per share on revenue of

Top 10 Gold Stocks To Watch Right Now: Lowe’s Companies Inc.(LOW)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Lowe's Companies, Inc. (NYSE: LOW) to report quarterly earnings at $1.25 per share on revenue of $17.63 billion before the opening bell. Lowe's shares declined 0.35 percent to $85.45 in pre-market trading.
    Analysts expect NetApp, Inc. (NASDAQ: NTAP) to post quarterly earnings at $1.01 per share on revenue of $1.60 billion after the closing bell. NetApp shares dropped 2.09 percent to close at $67.02 on Tuesday.
    Urban Outfitters, Inc. (NASDAQ: URBN) reported better-than-expected earnings for its fiscal first quarter on Tuesday. Urban Outfitters shares dropped 2.21 percent to $40.30 in the pre-market trading session.
    Before the markets open, Tiffany & Co. (NYSE: TIF) is projected to report quarterly earnings at $0.83 per share on revenue of $957.49 million. Tiffany shares gained 0.45 percent to $102.70 in pre-market trading.
    Analysts are expecting Target Corporation (NYSE: TGT) to have earned $1.38 per share on revenue of $16.50 billion in the latest quarter. Target will release earnings before the markets open. Target shares rose 0.07 percent to $75.52 in pre-market trading.
    Hewlett Packard Enterprise Co (NYSE: HPE) reported stronger-than-expected profit for its fiscal second quarter and raised its FY18 GAAP earnings outlook. Hewlett Packard Enterprise shares rose 0.40 percent to $17.48 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Logan Wallace]

    Prudential Financial Inc. lessened its position in shares of Lowe’s (NYSE:LOW) by 19.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 945,909 shares of the home improvement retailer’s stock after selling 230,358 shares during the period. Prudential Financial Inc. owned approximately 0.11% of Lowe’s worth $83,003,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Demitrios Kalogeropoulos]

    Lowe’s Companies Inc. (NYSE:LOW)is firmly in runner-up territory in the home improvement market. In its battle against Home Depot (NYSE:HD), the retailer comes up short in key metrics including sales growth, profitability, and financial efficiency.

  • [By Lisa Levin] Gainers
    Cara Therapeutics, Inc. (NASDAQ: CARA) shares surged 42.76 percent to close at $16.56 on Wednesday in reaction to a new licensing agreement with Europe-based Vifor Pharma. As part of the agreement, the biopharmaceutical company that alleviates pain licensed worldwide rights (except U.S., Japan, and South Korea) to Vifor Pharma to commercialize its KORSUVA therapy to Vifor $70 million.
    Yangtze River Port and Logistics Limited (NASDAQ: YRIV) gained 31.28 percent to close at $7.05 on Wednesday.
    Tiffany & Co. (NYSE: TIF) climbed 23.29 percent to close at $126.05 after the company reported upbeat results for its first quarter and raised its FY2018 earnings guidance.
    EVO Payments, Inc. (NASDAQ: EVOP) gained 18.88 percent to close at $19.02. EVO Payments priced its IPO at $16 per share.
    Carver Bancorp, Inc. (NASDAQ: CARV) rose 16.1 percent to close at $6.85.
    USA Technologies, Inc. (NASDAQ: USAT) gained 15.68 percent to close at $13.65 after announcing pricing of public offering.
    eXp World Holdings, Inc. (NASDAQ: EXPI) shares jumped 15.01 percent to close at $17.70.
    Geron Corporation (NASDAQ: GERN) gained 14.99 percent to close at $4.68.
    Evolus, Inc. (NASDAQ: EOLS) rose 14.62 percent to close at $19.36.
    Ralph Lauren Corporation (NYSE: RL) shares rose 14.34 percent to close at $133.33 after the company reported stronger-than-expected results for its fourth quarter.
    Turtle Beach Corporation (NASDAQ: HEAR) jumped 13.26 percent to close at $17.34 on Wednesday. Turtle Beach S-3 showed registration for 1.857 million share common stock offering via selling holders.
    Communications Systems, Inc. (NASDAQ: JCS) rose 13.18 percent to close at $3.95. Communications Systems reported establishment of special committee to explore strategic alternatives.
    Immutep Limited (NASDAQ: IMMP) shares climbed 12.95 percent to close at $2.53.
    xG Technology, Inc. (NASDAQ: XGTI) rose 12.64 percent to close at $0.8561 after the company&rsq
  • [By Daniel B. Kline]

    Lowe’s (NYSE:LOW) has found its next CEO in J.C. Penney (NYSE:JCP) boss Marvin R. Ellison. The hire, which goes into effect on July 2, closes a months-long search for a successor to Robert A. Niblock, who announced plans to retire in March.

Top 10 Gold Stocks To Watch Right Now: Telecom Argentina Stet – France Telecom S.A.(TEO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Friday morning, the telecommunication services shares rose 0.75 percent. Meanwhile, top gainers in the sector included Telecom Argentina S.A. (NYSE: TEO), up 6 percent, and pdvWireless, Inc. (NASDAQ: PDVW) up 4 percent.

  • [By Joseph Griffin]

    Telecom Argentina (NYSE:TEO) has been assigned an average recommendation of “Hold” from the nine research firms that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, three have assigned a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $38.00.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Telecom Argentina (TEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get Telecom Argentina alerts:

    Cablevisi贸n Holding Announces First Quarter 2018 Results (finance.yahoo.com) Zacks: Analysts Anticipate Telecom Argentina (TEO) Will Post Earnings of $0.39 Per Share (americanbankingnews.com) Telecom Argentina posts double-digit gains in Q1 (seekingalpha.com) Telecom Argentina S.A. announces consolidated first quarter results for fiscal year 2018 (‘1Q18’)* (finance.yahoo.com)

    Shares of Telecom Argentina opened at $23.57 on Wednesday, Marketbeat Ratings reports. The company has a market cap of $4.30 billion, a P/E ratio of 9.86, a price-to-earnings-growth ratio of 2.31 and a beta of 1.12. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.75 and a current ratio of 0.83. Telecom Argentina has a 52-week low of $21.38 and a 52-week high of $23.56.

Top 10 Gold Stocks To Watch Right Now: Euronav NV(EURN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Seanergy Maritime (NASDAQ: SHIP) and Euronav (NYSE:EURN) are both small-cap transportation companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Teradyne, Inc. (NYSE: TER) fell 10.8 percent to $37.02 in pre-market trading after the company issued downbeat Q2 guidance.
    Edwards Lifesciences Corporation (NYSE: EW) fell 9.2 percent to $122.29 in pre-market trading. Edwards Lifesciences reported better-than-expected results for its first quarter, but issued weak earnings guidance for the second quarter.
    New Gold Inc. (NYSE: NGD) fell 8.8 percent to $2.30 in pre-market trading after rising 4.13 percent on Tuesday.
    Gold Fields Limited (ADR) (NYSE: GFI) fell 8.6 percent to $3.61 in pre-market trading.
    Natus Medical Incorporated (NASDAQ: BABY) fell 8.2 percent to $32.95 in pre-market trading after the company issued weak forecast for the second quarter.
    Atossa Genetics Inc. (NASDAQ: ATOS) shares fell 7.9 percent to $3.50 in pre-market trading after climbing 27.09 percent on Tuesday.
    Bright Scholar Education Holdings Limited (NYSE: BEDU) shares fell 6.7 percent to $13.58 in pre-market trading after reporting Q1 results.
    Sangamo Therapeutics Inc (NASDAQ: SGMO) fell 5.9 percent to $16.75 in pre-market trading following announcement of a $200 million common stock offering.
    Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) shares fell 5.7 percent to $3.29 in pre-market trading after declining 3.32 percent on Tuesday.
    Euronav NV (NYSE: EURN) fell 4.8 percent to $8.40 in pre-market trading.
    Limelight Networks, Inc. (NASDAQ: LLNW) shares fell 4.3 percent to $4.69 in pre-market trading.
    Gaming and Leisure Properties Inc (NASDAQ: GLPI) shares fell 4.1 percent to $32.92 in pre-market trading after the company issued downbeat quarterly results and reported the retirement of CFO William Clifford

Top 10 Gold Stocks To Watch Right Now: Marsh & McLennan Companies, Inc.(MMC)

Advisors’ Opinion:

  • [By Max Byerly]

    Marsh & McLennan Companies (NYSE: MMC) and Kering (OTCMKTS:PPRUY) are both large-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.

Top 10 Gold Stocks To Watch Right Now: Innophos Holdings, Inc.(IPHS)

Advisors’ Opinion:

  • [By Max Byerly]

    BidaskClub upgraded shares of Innophos (NASDAQ:IPHS) from a strong sell rating to a sell rating in a research report report published on Friday morning.

Best Biotech Stocks To Invest In Right Now

Introduction

ContraVir Pharmaceuticals (CTRV) is a clinical-stage biotech company focused on the development of small-molecule antivirals for Chronic Hepatitis B. ContraVir has developed a strong Hepatitis B pipeline consisting of two small-molecule antiviral agents. With a novel cyclophilin inhibitor and a next-generation reverse transcriptase inhibitor, ContraVir hopes to become the first drug company to bring the first-of-its-kind antiviral combination therapy to the market for the treatment of Hepatitis B. Unlike Hepatitis C or HIV, a small-molecule antiviral combination therapy regimen has not yet been developed for Hepatitis B. ContraVir believes that if approved by the FDA, their small-molecule multi-antiviral agent combination therapy approach can lead to a dramatic therapeutic improvement over the current standard of care. Furthermore, the market has disregarded that ContraVir’s drug candidates can also be utilized for the potential treatment of other diseases and conditions including HIV-1. With the market ignoring their full potential, ContraVir’s stock price has continued to fall to all-time lows. Due to the collapse in stock price that began well over a year ago, ContraVir is now faced with a very low market cap and a NASDAQ price listing requirement violation. Despite their short-term troubles, ContraVir can be an excellent investment opportunity for those willing to take a speculative risk now or those willing to play it safer by waiting out the storm.

Best Biotech Stocks To Invest In Right Now: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Chris Lange]

    NocoCure Ltd. (NASDAQ: NVCR) is scheduled to release its fourth-quarter earnings report on February 22 as well. The consensus estimates call for a net loss of $0.11 per share and $53.52 million in revenue. The same period of last year had a net loss of $0.26 per share and $30.24 million in revenue. Shares of Novocure most recently closed at $21.50, with a consensus price target of $27.00 and a 52-week range of $6.75 to $24.15.

  • [By Brian Feroldi]

    After the company reported first-quarter results, shares of NovoCure (NASDAQ:NVCR), a medical device company focused on cancer, jumped as much as 10% in afternoon trading on Thursday. Shares closed the day up more than 9%.

  • [By Lee Jackson]

    This stock has been on a roll and looks ready to break out. NovoCure Ltd. (NASDAQ: NVCR) develops and commercializes treatments for solid tumor cancer therapy called the tumor treating fields (TTFields). Its markets its proprietary TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer.

Best Biotech Stocks To Invest In Right Now: Nicholas Financial Inc.(NICK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Nicholas Financial (NASDAQ: NICK) and Encore Capital Group (NASDAQ:ECPG) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

  • [By Stephan Byrd]

    Nicholas Financial (NASDAQ: NICK) and CPI Card Group (NASDAQ:PMTS) are both small-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

  • [By Max Byerly]

    CPI Card Group (NASDAQ: PMTS) and Nicholas Financial (NASDAQ:NICK) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Best Biotech Stocks To Invest In Right Now: Sun Hydraulics Corporation(SNHY)

Advisors’ Opinion:

  • [By Neha Chamaria]

    When Sun Hydraulics Corporation (NASDAQ:SNHY) reported its first-quarter 2018 numbers on May 7, the one thing that stood out in the earnings report was its top-line growth. Strong demand for industrial valves and electronics instrumentation combined with Sun Hydraulics’ opportunistic growth moves encouraged the company to upgrade its full-year sales outlook.

Best Performing Stocks To Own For 2019

Related BZF Brazil Soap Opera Continues With Arrest Of Former Finance Minister Why India ETFs, Why Now
Related EWZ ETFs Not Getting Any Help From China Latin America Steering To The Right: From Colombia To Brazil, Things Are Changing Fast Finding The Outperforming Country ETFs By Watching The Currency Trends (Seeking Alpha)

It’s a bittersweet day for democracy: while some celebrate the prevalence of the judicial system and democratic checks and balances, others mourn the loss of a popular leader that, some say, was unjustly removed from her position in a move repeatedly characterized as a coup d’état.

Best Performing Stocks To Own For 2019: Lyon William Homes(WLH)

Advisors’ Opinion:

  • [By Max Byerly]

    William Lyon Homes (NYSE:WLH) traded down 7.4% on Tuesday . The company traded as low as $24.95 and last traded at $25.04. 774,270 shares were traded during trading, an increase of 81% from the average session volume of 426,618 shares. The stock had previously closed at $27.05.

Best Performing Stocks To Own For 2019: National Beverage Corp.(FIZZ)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    In this segment from the Motley Fool Money podcast, host Chris Hill is joined by Jason Moser of Million Dollar Portfolio, David Kretzmann of Hidden Gems Canada, and Aaron Bush of Motley Fool Rule Breakers to discuss the stocks on their radar. Find out why National Beverage (NASDAQ:FIZZ), JPMorgan Chase (NYSE:JPM), and Autodesk (NASDAQ:ADSK) have piqued their interest.

  • [By Jeremy Bowman]

    The company appears to have solved that problem by remaking itself as a sparkling water brand. Not only does that make the product more attractive from a pricing perspective as it’s competing with more expensive bottled waters, but the company is now benefiting from tailwinds in consumer trends as more consumers are drinking bottled and sparkling water in part because of its perceived health benefits compared to soda.Shares ofNational Beverage(NASDAQ:FIZZ) have soared recently on the strength of LaCroix, the flavored sparkling water brand that has developed a following among millennials. In the U.S., sparkling water sales were expected to grow by more than a third last year and from 2011 to 2017 sales of the fizzy water.

Best Performing Stocks To Own For 2019: Advance Auto Parts Inc(AAP)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Advance Auto Parts, Inc. (NYSE: AAP) which rose 4% to $114.21. The stocks 52-week range is $78.81 to $158.59. Volume was nearly 2 million compared to the daily average volume of 1.5 million.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Advance Auto Parts, Inc. (NYSE: AAP) which rose over 8% to $114.18. The stocks 52-week range is $78.81 to $161.99. Volume was 5 million compared to the daily average volume of 1.4 million.

Best Performing Stocks To Own For 2019: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Chris Lange]

    NocoCure Ltd. (NASDAQ: NVCR) is scheduled to release its fourth-quarter earnings report on February 22 as well. The consensus estimates call for a net loss of $0.11 per share and $53.52 million in revenue. The same period of last year had a net loss of $0.26 per share and $30.24 million in revenue. Shares of Novocure most recently closed at $21.50, with a consensus price target of $27.00 and a 52-week range of $6.75 to $24.15.

  • [By Brian Feroldi]

    After the company reported first-quarter results, shares of NovoCure (NASDAQ:NVCR), a medical device company focused on cancer, jumped as much as 10% in afternoon trading on Thursday. Shares closed the day up more than 9%.

  • [By Lee Jackson]

    This stock has been on a roll and looks ready to break out. NovoCure Ltd. (NASDAQ: NVCR) develops and commercializes treatments for solid tumor cancer therapy called the tumor treating fields (TTFields). Its markets its proprietary TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer.

  • [By Todd Campbell, Sean Williams, and Brian Feroldi]

    There have been more stock market pops and drops lately and that might have you wondering what healthcare stocks can be bought to take advantage of this volatility. Buying healthcare stocks during periods of volatility can be smart because demand for healthcare products and services usually isn’t discretionary. However, that doesn’t necessarily mean it makes sense to buy every healthcare stock out there. To find out what healthcare stocks it might make sense to buy this month, we asked top Motley Fool investors what companies are on their radar. In their view,Teva Pharmaceutical Industries (NYSE:TEVA), Novacure (NASDAQ:NVCR), and Galapagos (NASDAQ:GLPG)should be at the top of your idea list right now. Read on to find out why.

Top 5 Performing Stocks To Buy Right Now

With Dow 22,000 alerting Main Street investors to the fact stocks are at record highs, its a good time to reiterate that August has been the worst-performing month for the Dow the past 20 years. The Dow has fallen 1.4%, on average, in August and finished up just 50% of the time.

So what events in August could derail the Dows record run? LPL Financials chief wealth strategist Matthew Peterson and senior market strategist Ryan Detrick compiled a watch list:

Jobs report: The July employment report will be released Friday. Wall Street is looking for a continuation of the upbeat report in June, when the economy created 222,000 jobs. LPL is expecting 180,000 new jobs in August.

Inflation update: The Federal Reserve has hiked interest rates twice this year. But tepid inflation in recent months has complicated its future hike plans. On Aug. 11, investors will get a look at July inflation at the consumer level. If it is weak and stays south of the Feds 2% goal, the rate-hike schedule could be pushed back.

Top 5 Performing Stocks To Buy Right Now: MV Oil Trust(MVO)

Advisors’ Opinion:

  • [By Max Byerly]

    MV Oil Trust (NYSE: MVO) and Petroleo Brasileiro SA Petrobras (NYSE:PBR.A) are both oils/energy companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

Top 5 Performing Stocks To Buy Right Now: Equus Total Return, Inc.(EQS)

Advisors’ Opinion:

  • [By Anders Melin]

    Taking that a step further, you can run searches on the Equity Screening (EQS) function using the new pay metrics or data on say-on-pay, which refers to shareholders’ right to vote on management remuneration. To see Russell 1000 companies with the lowest support on pay, for example, go to {EQS <GO>}. In the Add Criteria field, enter RIY and click on the Russell 1000 Index match. Next, enter Say on Pay, click on the Say on Pay Support Level item, and press <GO>. Click on the See Results | WATC button for a list of companies in the benchmark that you can sort by the percentage of shareholders supporting management on pay.

Top 5 Performing Stocks To Buy Right Now: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Brian Feroldi]

    After the company reported first-quarter results, shares of NovoCure (NASDAQ:NVCR), a medical device company focused on cancer, jumped as much as 10% in afternoon trading on Thursday. Shares closed the day up more than 9%.

  • [By Todd Campbell, Sean Williams, and Brian Feroldi]

    There have been more stock market pops and drops lately and that might have you wondering what healthcare stocks can be bought to take advantage of this volatility. Buying healthcare stocks during periods of volatility can be smart because demand for healthcare products and services usually isn’t discretionary. However, that doesn’t necessarily mean it makes sense to buy every healthcare stock out there. To find out what healthcare stocks it might make sense to buy this month, we asked top Motley Fool investors what companies are on their radar. In their view,Teva Pharmaceutical Industries (NYSE:TEVA), Novacure (NASDAQ:NVCR), and Galapagos (NASDAQ:GLPG)should be at the top of your idea list right now. Read on to find out why.

  • [By Lee Jackson]

    This stock has been on a roll and looks ready to break out. NovoCure Ltd. (NASDAQ: NVCR) develops and commercializes treatments for solid tumor cancer therapy called the tumor treating fields (TTFields). Its markets its proprietary TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer.

  • [By Chris Lange]

    NocoCure Ltd. (NASDAQ: NVCR) is scheduled to release its fourth-quarter earnings report on February 22 as well. The consensus estimates call for a net loss of $0.11 per share and $53.52 million in revenue. The same period of last year had a net loss of $0.26 per share and $30.24 million in revenue. Shares of Novocure most recently closed at $21.50, with a consensus price target of $27.00 and a 52-week range of $6.75 to $24.15.

Top 5 Performing Stocks To Buy Right Now: ANI Pharmaceuticals, Inc.(ANIP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Canaccord Genuity set a $82.00 target price on ANI Pharmaceuticals (NASDAQ:ANIP) in a research report released on Tuesday morning. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.

Top 5 Performing Stocks To Buy Right Now: Blue Capital Reinsurance Holdings Ltd.(BCRH)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Here are some of the headlines that may have impacted Accern’s rankings:

    Get Akari Therapeutics alerts:

    Akari Therapeutics, Plc (AKTX) Analysts See $-1.00 EPS; HC INTERNATIONAL ORDINARY SHARES CA (HCINF … (mtastar.com) Trader’s Buzzers- Boxlight Corporation (NASDAQ:BOXL), Blue Capital Reinsurance Holdings Ltd. (NYSE:BCRH), Akari … (journalfinance.net) Akari Therapeutics (AKTX) Lifted to “Hold” at ValuEngine (americanbankingnews.com) Guillain-Barre Syndrome Market to reach value of US$ 708.6 Mn by 2025, Says TMRGlobal GuillainBarre Syndrome … (markets.businessinsider.com) Analysts See $-1.00 EPS for Akari Therapeutics, Plc (AKTX); Verastem (VSTM) SI Decreased By 7.78% (mtastar.com)

    Several brokerages have commented on AKTX. ValuEngine upgraded Akari Therapeutics from a “sell” rating to a “hold” rating in a research note on Wednesday. Canaccord Genuity cut their target price on Akari Therapeutics from $15.00 to $8.00 and set a “buy” rating for the company in a research note on Thursday, March 29th. B. Riley began coverage on Akari Therapeutics in a research note on Thursday, February 8th. They issued a “neutral” rating and a $3.00 target price for the company. Finally, Zacks Investment Research downgraded Akari Therapeutics from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, January 16th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $4.63.

  • [By Shane Hupp]

    Blue Capital Reinsurance (NYSE:BCRH) reached a new 52-week high and low during trading on Thursday . The company traded as low as $10.90 and last traded at $11.05, with a volume of 17133 shares trading hands. The stock had previously closed at $11.20.

Best Clean Energy Stocks To Buy Right Now

A month ago, Teslas closing stock price peaked at $383.45, and last week the stock closed below $330.

Tesla Inc. Powerpacks and inverters stand at the Southern California Edison Co. Mira Loma energy storage system facility in Ontario, California, U.S., on Thursday, June 1, 2017. The Mira Loma substation houses nearly 400 Tesla Powerpack units, in an effort to operate to state regulations on producing clean energy electricity. Photographer: Patrick T. Fallon/Bloomberg

Apparently, investors are beginning to catch on to the fact that Tesla CEO Elon Musk has a severe case of a behavioral condition known as the planning fallacy. People who suffer from the planning fallacy are serial offenders when it comes to projects coming in over budget, late, and with fewer features than promised. The New York Times reported that Telsa’s main problematic issues pertain to a slower timetable than expected for the introduction of the Model 3, along with problems that relate to the manufacture of its battery packs.

Best Clean Energy Stocks To Buy Right Now: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Todd Campbell, Sean Williams, and Brian Feroldi]

    There have been more stock market pops and drops lately and that might have you wondering what healthcare stocks can be bought to take advantage of this volatility. Buying healthcare stocks during periods of volatility can be smart because demand for healthcare products and services usually isn’t discretionary. However, that doesn’t necessarily mean it makes sense to buy every healthcare stock out there. To find out what healthcare stocks it might make sense to buy this month, we asked top Motley Fool investors what companies are on their radar. In their view,Teva Pharmaceutical Industries (NYSE:TEVA), Novacure (NASDAQ:NVCR), and Galapagos (NASDAQ:GLPG)should be at the top of your idea list right now. Read on to find out why.

  • [By Chris Lange]

    NocoCure Ltd. (NASDAQ: NVCR) is scheduled to release its fourth-quarter earnings report on February 22 as well. The consensus estimates call for a net loss of $0.11 per share and $53.52 million in revenue. The same period of last year had a net loss of $0.26 per share and $30.24 million in revenue. Shares of Novocure most recently closed at $21.50, with a consensus price target of $27.00 and a 52-week range of $6.75 to $24.15.

  • [By Brian Feroldi]

    After the company reported first-quarter results, shares of NovoCure (NASDAQ:NVCR), a medical device company focused on cancer, jumped as much as 10% in afternoon trading on Thursday. Shares closed the day up more than 9%.

  • [By Lee Jackson]

    This stock has been on a roll and looks ready to break out. NovoCure Ltd. (NASDAQ: NVCR) develops and commercializes treatments for solid tumor cancer therapy called the tumor treating fields (TTFields). Its markets its proprietary TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer.

Best Clean Energy Stocks To Buy Right Now: Versum Materials, Inc. (VSM)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about Versum Materials (NYSE:VSM) have been trending somewhat positive recently, Accern reports. The research group identifies negative and positive press coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Versum Materials earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave media headlines about the basic materials company an impact score of 46.4354866491979 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

Best Clean Energy Stocks To Buy Right Now: Rosetta Resources Inc.(ROSE)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares climbed 70.3 percent to $5.45 after reporting 2017 year-end results.
    MEDIGUS Ltd/S ADR (NASDAQ: MDGS) surged 39.8 percent to $1.58 in reaction to its Monday announcement of a distribution agreement. The medical device company said it reached an agreement to distribute its minimally invasive medical devices in Turkey, Azerbaijan and Georgia.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) gained 25.6 percent to $11.50. Arcadia Biosciences reported that Albert D. Bolles, Ph.D. has joined its board of directors.
    Aytu Bioscience Inc (NASDAQ: AYTU) shares jumped 21.8 percent to $0.4798 after the company late Monday reported lighter-than-expected Q1 loss.
    Hollysys Automation Technologies Ltd. (NASDAQ: HOLI) shares gained 21.1 percent to $26.77 following Q3 results.
    Pfenex Inc. (NYSE: PFNX) rose 16.8 percent to $7.1271 after the company announced the positive top-line PF708 study results in Osteoporosis patients that showed no imbalances in severity or incidence of adverse events.
    MEI Pharma, Inc. (NASDAQ: MEIP) rose 13.8 percent to $2.88.
    Red Violet, Inc. (NASDAQ: RDVT) jumped 13.1 percent to $6.41 after reporting Q1 results.
    SORL Auto Parts, Inc. (NASDAQ: SORL) shares gained 12 percent to $5.87 after reporting upbeat Q1 results.
    Bovie Medical Corporation (NYSE: BVX) gained 8.4 percent to $3.96 after reporting a first-quarter sales beat.
    Rosehill Resources Inc. (NASDAQ: ROSE) surged 8.4 percent to $7.90 after announcing Q1 results.
    LiqTech International, Inc. (NASDAQ: LIQT) rose 8.1 percent to $0.5171 following Q1 results.
    ProPhase Labs, Inc. (NASDAQ: PRPH) rose 7.7 percent to $5.6103 following Q1 results.
    Nine Energy Service, Inc. (NYSE: NINE) shares climbed 7.4 percent to $35.90.
    Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 6.7 percent to $6.40 after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data.
    MYnd

Best Clean Energy Stocks To Buy Right Now: Broadwind Energy Inc.(BWEN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Matthews International (NASDAQ: MATW) and Broadwind Energy (NASDAQ:BWEN) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership.

  • [By Shane Hupp]

    Matthews International (NASDAQ: MATW) and Broadwind Energy (NASDAQ:BWEN) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends.

Top Value Stocks To Invest In 2018

The Q1 2017 earnings report for small cap poultry processing stock Sanderson Farms, Inc (NASDAQ: SAFM) is scheduled for before the market opens on Thursday (February 23rd) as shares still have elevated short interest of 33.50% according to Highshortinterest.comdue in part to fears over bird flu.

A technical chartshows shares backin an uptrend and heading towards a key resistance level:

A long term performance chart shows shares of small cap Sanderson Farms doubling in value while mid cap Pilgrim’s Pride Corporation (NASDAQ: PPC) and large cap Tyson Foods, Inc (NYSE: TSN) have been even better performers albeit they are off their former peaks:

Top Value Stocks To Invest In 2018: Cherry Hill Mortgage Investment Corporation(CHMI)

Advisors’ Opinion:

  • [By Lisa Levin] Related Mid-Afternoon Market Update: CytomX Therapeutics Climbs Following Bristol-Myers Squibb Partnership; Medgenics Shares Slide 15 Biggest Mid-Day Losers For Monday Cerulean Pharma's (CERU) CEO Chris Guiffre on Cerulean and Dar茅 Proposed Transaction (Transcript) (Seeking Alpha)
    Related Mid-Afternoon Market Update: Cancer Genetics Gains After Q4 Results; Heat Biologics Shares Slide Mid-Day Market Update: Dow Rises Over 50 Points; Tandem Diabetes Care Shares Plunge Tandem Diabetes prices stock offering at $1.25; shares off 19% premarket (Seeking Alpha)
    Cerulean Pharma Inc (NASDAQ: CERU) shares dipped 27 percent to $0.817. Cerulean Pharma shares have dropped 60.28 percent over the past 52 weeks, while the S&P 500 index has gained 15.31 percent in the same period.
    Tandem Diabetes Care Inc (NASDAQ: TNDM) shares tumbled 24.2 percent to $1.17. Tandem Diabetes Care priced 18 million share offering at $1.25 per share.
    Alphatec Holdings Inc (NASDAQ: ATEC) shares fell 21.1 percent to $2.10 as the company reported a $18.9 million private placement.
    Heat Biologics Inc (NASDAQ: HTBX) shares dropped 15.5 percent to $0.870. Heat Biologics priced its 5 million share offering at $0.80 per share.
    Rave Restaurant Group Inc (NASDAQ: RAVE) shares fell 15 percent to $1.76.
    QuickLogic Corporation (NASDAQ: QUIK) shares declined 12.2 percent to $1.58. QuickLogic priced its 10 million share offering at $1.50 per share.
    Orion Engineered Carbons SA (NYSE: OEC) shares dropped 9.5 percent to $19.10. Orion Engineered Carbons reported a 5 million common stock secondary offering.
    Interpace Diagnostics Group Inc (NASDAQ: IDXG) shares fell 8.7 percent to $2.61 after the company reported debt restructuring and agreed to eliminate its royalty and mileston

Top Value Stocks To Invest In 2018: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Brian Orelli]

    Genomic Health (NASDAQ:GHDX) closed up 10.2% Tuesday following its announcement of solid fourth-quarter earnings after the bell Monday. The company’s 2017 guidance certainly didn’t hurt investors’ confidence either.

  • [By Brian Orelli]

    Genomic Health (NASDAQ:GHDX) swung to a profit in the fourth quarter on the back of solid revenue growth and expects to have another productive year in 2017 as the company continues to increase reimbursement for its genetic tests.

Top Value Stocks To Invest In 2018: NovoCure Limited(NVCR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Novocure Ltd (NASDAQ: NVCR) shares shot up 22 percent to $7.27 after the company posted a narrower-than-expected Q3 loss.

    Shares of TriNet Group Inc (NYSE: TNET) got a boost, shooting up 15 percent to $20.43. TriNet reported Q3 earnings of $0.29 per share on revenue of $770.5 million.

  • [By Chris Lange]

    NocoCure Ltd. (NASDAQ: NVCR) is scheduled to release its fourth-quarter earnings report on February 22 as well. The consensus estimates call for a net loss of $0.11 per share and $53.52 million in revenue. The same period of last year had a net loss of $0.26 per share and $30.24 million in revenue. Shares of Novocure most recently closed at $21.50, with a consensus price target of $27.00 and a 52-week range of $6.75 to $24.15.